Metabolic syndrome in hospitalized patients with chronic obstructive pulmonary disease

Introduction. The metabolic syndrome (MS) affects 21–53% of patients with chronic obstructive pulmonary disease (COPD) with a higher prevalence in the early stages of COPD, with results being highly variable between studies. MS may also affect natural course of COPD—number of exacerbations, quality...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:PeerJ
Egile Nagusiak: Mekov, Evgeni, Slavova, Yanina, Tsakova, Adelina, Genova, Marianka, Kostadinov, Dimitar, Minchev, Delcho, Marinova, Dora
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: PeerJ Inc. 2015
Gaiak:
Diabetes and Endocrinology
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4493698/
https://ncbi.nlm.nih.gov/pubmed/26157632
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7717/peerj.1068
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak